PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Researchers receive grant worth millions to develop portable PET scanner
Experts are hopeful that the portable scanner could improve access to neuroimaging used in the diagnosis and monitoring of Alzheimer's disease.
Understanding hospital billing for cardiac PET/CT
Significant fluctuations in PET and CT reimbursement rates have made it especially challenging to keep up with this complex topic. We spoke to an expert to learn more.
Lizard saliva could be key to spotting elusive pancreatic tumors
By binding the substance to a radiotracer, experts were able to improve the accuracy of identifying these tumors by as much as 30% compared to the standard of care.
FDA approves GE HealthCare's flurpiridaz F-18 PET radiotracer for CAD
The newly approved radiotracer is seen as a major step forward for nuclear imaging technology. Specialists have been looking forward to its arrival on the market for quite some time.
Novel radiotracer could improve the diagnosis of interstitial lung disease
Researchers are hopeful that uptake of the molecular SPECT imaging agent will help providers more ably monitor disease progression.

Prominent imaging society advocates for 5 changes following CMS amyloid PET payment decision

SNMMI is fighting for expanded coverage for amyloid PET, including broadening accepted sites of service, among other changes.

February 23, 2022

New advanced PET imaging reveals root of cognitive decline in patients with Alzheimer's

The scans unearthed a significant association between synaptic density and decreased cognitive performance, Yale researchers revealed recently.

February 17, 2022

Is PET/CT or multiparametric MRI best for detecting prostate cancer? New research offers guidance

A comparison of the detection rates for 68Ga-PSMA PET/CT and mpMRI in low, intermediate and high-risk prostate cancer was recently shared by experts in EJNMMI.

February 14, 2022

F-18 FDG PET/CT highly sensitive for diagnosing cause of fevers with unknown origin

Such scans determined the final diagnosis in 54% of patients and were more accurate than CRP and WBC levels for identifying fever origin, according to research published in Scientific Reports.

February 10, 2022

PSMA-PET validates commonly used system measuring risk of prostate cancer recurrence

"The accuracy of PSMA-PET is essential to improve stratification and potentially outcomes both in low-risk and high-risk settings,” a doctor involved in the study explained in the Journal of Nuclear Medicine.

January 21, 2022

SNMMI images of unusual imaging pattern observed on FDG PET/CT or FDG PET/MR that may be due to Omicron COVID-19 infection. Unlike the FDG PET/CT pattern seen with infections from previous strains of COVID-19, with principal involvement of the lungs, this new array of findings is primarily centered in the upper aerodigestive tract and cervical lymph nodes. What does omnicron COVID look like in medical imaging?

Unusual pattern on PET/CT may indicate COVID omicron variant

The Society of Nuclear Medicine and Molecular Imaging offered up a handful of tips to help providers who encounter such findings.

January 14, 2022

Machine learning combined with PET/CT can predict heart attack risk

“We showed that risk prediction does not depend on cardiovascular risk scores, stenosis severity or CT calcium scoring," researchers said in the Journal of Nuclear Medicine.

January 12, 2022

Physicians support use of PET/CT scans in pregnant women with cancer, survey finds

Researchers say scans pose little risk to an unborn fetus but maintained doctors must weigh the benefits against potential risks.

October 28, 2021

PET/CT

Researchers receive grant worth millions to develop portable PET scanner

Understanding hospital billing for cardiac PET/CT

Lizard saliva could be key to spotting elusive pancreatic tumors

FDA approves GE HealthCare's flurpiridaz F-18 PET radiotracer for CAD

Novel radiotracer could improve the diagnosis of interstitial lung disease